Search results
Results from the WOW.Com Content Network
Of the platinum compounds, research has shown cisplatin to be the most frequently involved in peripheral neuropathy. [3] 2) Taxanes, including paclitaxel (and protein-bound pactiltaxel e.g. abraxane), docetaxel, and cabazitaxel, are used to treat ovarian, breast, non-small cell lung, and prostate cancers. [3]
Cisplatin is a chemical compound with formula cis-[Pt(NH 3) 2 Cl 2]. It is a coordination complex of platinum that is used as a chemotherapy medication used to treat a number of cancers . [ 3 ] These include testicular cancer , ovarian cancer , cervical cancer , bladder cancer , head and neck cancer , esophageal cancer , lung cancer ...
Macmillan Cancer Support merged with cancer information charity Cancerbackup in 2008. Macmillan works in partnership with other cancer research organisations and is a partner of the National Cancer Research Institute. Macmillan is part of the Richmond Group of Charities, which is a coalition of 14 leading health and social care organisations in ...
Learn more about the AOL app and download it from the App Store. The AOL app is available for iOS devices running iOS 12 or newer. Open the App Store on your device. Tap the Search icon. Type "AOL" in the search field. Tap Search. Next to "AOL: News Email Weather Video", tap Get. Enter your Touch ID or Apple ID, if prompted. Tap Open.
Get the tools you need to help boost internet speed, send email safely and security from any device, find lost computer files and folders and monitor your credit.
A chemotherapy regimen is a regimen for chemotherapy, defining the drugs to be used, their dosage, the frequency and duration of treatments, and other considerations.In modern oncology, many regimens combine several chemotherapy drugs in combination chemotherapy.
In 1999, Johnson & Johnson had signed a contract with a company called Excerpta Medica. Its specialty was medical marketing. Its sub-specialty was producing ghostwritten, data-filled studies on the efficacy and safety of a client’s drugs, finding the right academic scholars to be listed as the authors and then placing the articles in prestigious academic journals.
Carboplatin, a cisplatin analogue, was developed by Bristol Myers Squibb and the Institute of Cancer Research in order to reduce the toxicity of cisplatin. [6] [20] It gained U.S. Food and Drug Administration (FDA) approval for carboplatin, under the brand name Paraplatin, in March 1989. Starting in October 2004, generic versions of the drug ...